Jiaying Fu
Overview
Explore the profile of Jiaying Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu S, Zhao Y, Liu Q, Wang J, Fu J, Li R, et al.
Bioorg Chem
. 2025 Jan;
155():108135.
PMID: 39793221
Purpose: Understanding the molecular mechanisms of adaptive regulation in the tumor microenvironment is crucial for precision therapy in hepatocellular carcinoma (HCC). We hypothesized that cargo proteins carried by extracellular vesicles...
2.
Liu Q, Yan X, Yuan Y, Li R, Zhao Y, Fu J, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338855
Systemic chronic inflammation (SCI) due to intrinsic immune over-activation is an important factor in the development of many noninfectious chronic diseases, such as neurodegenerative diseases and diabetes mellitus. Among these...
3.
Liu Q, Yan X, Li R, Yuan Y, Wang J, Zhao Y, et al.
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38256070
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, and, with increasing research on the tumor immune microenvironment (TIME), the immunosuppressive micro-environment of HCC hampers further application of immunotherapy,...
4.
Fu J, Lin Q, Ai B, Li M, Luo W, Huang S, et al.
Ecotoxicol Environ Saf
. 2023 Dec;
269:115792.
PMID: 38064789
Objective: We examined the relationships between infants' growth trajectories and prenatal exposure to air pollution, which is still under-investigated. Methods: A birth cohort study was constructed using medical records of...
5.
Wang J, Fu J, Zhao Y, Liu Q, Yan X, Su J
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003544
Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide. β-amyloid plaque (Aβ) deposition and hyperphosphorylated tau, as well as dysregulated energy metabolism in the brain, are key factors in...
6.
Xu L, Yan X, Wang J, Zhao Y, Liu Q, Fu J, et al.
Int J Mol Sci
. 2023 Oct;
24(20).
PMID: 37894746
Ovarian cancer is the most lethal gynecologic malignancy, and metastasis is the major cause of death in patients with ovarian cancer, which is regulated by the coordinated interplay of genetic...
7.
Fu J, Chai C, Chen L, Cai M, Ai B, Li H, et al.
Inflamm Bowel Dis
. 2023 Oct;
30(10):1812-1819.
PMID: 37889850
Background: We examined the associations of fish and fish oil consumption with inflammatory bowel disease (IBD) incidence. Patients And Methods: We conducted a longitudinal analysis based on the UK Biobank,...
8.
Wang J, Liu Q, Zhao Y, Fu J, Su J
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569723
Cisplatin is a first-line clinical agent used for treating solid tumors. Cisplatin damages the DNA of tumor cells and induces the production of high levels of reactive oxygen species to...
9.
Ai B, Chen L, Cai M, Fu J, Li H, Lin H, et al.
J Gerontol A Biol Sci Med Sci
. 2023 May;
79(2).
PMID: 37158699
Background: We investigated the associations between habitual use of glucosamine and incident dementia and Parkinson's disease in a population-based cohort. Methods: Using the UK Biobank data, we included around 0.29...
10.
Yang S, Zhang K, Hou J, Liu X, Xu D, Chen X, et al.
J Transl Med
. 2023 Apr;
21(1):262.
PMID: 37069645
Background: Multiple preclinical studies have reported a beneficial effect of extracellular vesicles (EVs), especially mesenchymal stem cells derived EVs (MSC-EVs), in the treatment of sepsis. However, the therapeutic effect of...